Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
53.85
-0.22 (-0.41%)
Aug 15, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
| Life Sciences | 810.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Growth | -19.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care | 634.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Growth | -4.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives | 572.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Growth | -8.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates | 144.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Growth | -4.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from | -47.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Growth | -10.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
| Other | 197.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 585.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Operating Income | 168.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Operating Income Growth | -265.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Operating Income | 73.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care Operating Income Growth | 8.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Operating Income | -32.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives Operating Income Growth | 542.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Operating Income | 29.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 197.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 585.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other Operating Income | -264.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other Operating Income Growth | 13.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
| Life Sciences EBITDA | 229.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences EBITDA Growth | -11.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care EBITDA | 152.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Personal Care EBITDA Growth | -3.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives EBITDA | 89.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Additives EBITDA Growth | 10.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates EBITDA | 42.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intermediates EBITDA Growth | -23.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other EBITDA | -264.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Unallocated and Other EBITDA Growth | 13.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
| United States | 624.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 1.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2014 - 2019 |
| Change in Sales Due to Volume | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Volume Growth | -234.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Product Pricing/Mix | -78.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Change in Sales Due to Product Pricing/Mix Growth | -54.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|